R

Rheumatic Disease Center | Glendale, WI

Research site

(Unclaimed)

Location

7080 N. Port Washington Road, Glendale, Wisconsin, United States of America

Site insights

Top conditions

Top treatments

Methotrexate

Baricitinib

Tocilizumab

MTX

Ocrelizumab

belimumab

CHS-0214

methotrexate

RO7790121

Lenabasum

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 20 total trials

A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)

This study will assess the efficacy and safety of Afimkibart (also known as RO7790121) compared with placebo in participants with moderate to severe...

Enrolling

Rheumatoid Arthritis

Drug: Placebo

Drug: Afimkibart

Trial sponsors

H

C

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms